| | | | | | | | | | |
|
|
|
|
| Dockets Entered On
January 9, 2006
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
|
|
| 2002N-0273
|
| Animal Proteins Prohibited in Ruminant Feed
|
|
|
|
|
| 2003P-0132
|
| Part 135 FDA regulations standard of identity frozen dessert
|
|
|
|
|
| 2004D-0493
|
| Draft Guidance for Industry on Recommended Approaches to Integration of Genetic Toxicology Study Results
|
|
|
|
|
| 2005D-0195
|
| Guidance for Industry and FDA Staff; The Mammography Quality Standards Act Final Regulations: Modifications and Additions to Policy Guidance Help System #9
|
|
|
|
|
| 2005D-0330
|
| Guidance for Industry and FDA Review Staff on Collection of Platelets by Automated Methods
|
|
|
|
|
| 2005D-0391
|
| Guidance for Industry and Food and Drug Administration Staff; Functional Indications for Implantable Cardioverter Defibrillators
|
|
|
|
|
| 2005N-0178
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Regulations Under the Federal Import Milk Act
|
|
|
|
|
| 2005N-0216
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Medical Devices: Humanitarian Use Devices
|
|
|
|
|
| 2005N-0217
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Cosmetic Product Voluntary Reporting Program
|
|
|
|
|
| 2005N-0394
|
| FDAs Communication of Drug Safety Information; Public Hearing
|
|
|
|
|
| 2005P-0377
|
| Petition to Rescind the "Generally Recognized as Safe" or GRAS Status for Aluminum Based Food Additives
|
|
|
|
|
| 2005P-0384
|
| Deficient Peripheral Metabolism of Thyroxine to Triiodothyronine
|
|
|
|
|
| 2005P-0411
|
| Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
|
|
|
|
|
| 2006V-0013
|
| Projector for a Laser Light Show
|
|
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
|
|
| LET
17096
|
| Enzymatic Therapy
|
| Vol #:
|
| 155
|
|
|
|
|
| LET
17097
|
| Enzymatic Therapy
|
| Vol #:
|
| 155
|
|
|
|
|
| LET
17098
|
| New Chapter, Inc.
|
| Vol #:
|
| 155
|
|
|
|
|
| LET
17099
|
| Pure Encapsulations
|
| Vol #:
|
| 155
|
|
|
|
|
| LET
17100
|
| ProBactive Biotech, Inc.
|
| Vol #:
|
| 155
|
|
|
|
|
| LET
17101
|
| Chattem, Inc.
|
| Vol #:
|
| 155
|
|
|
|
|
| 2002N-0273
|
| Animal Proteins Prohibited in Ruminant Feed
|
|
|
|
|
| C
519
|
| Edmonson County Fiscal Court
|
| Vol #:
|
| 40
|
|
| |
|
| 2003P-0132
|
| Part 135 FDA regulations standard of identity frozen dessert
|
|
|
|
|
| EC
59
|
| Ms. Elizabeth M. Ferranti
|
| Vol #:
|
| 4
|
|
|
|
|
| EC
60
|
| Mr. Leon A Lof
|
| Vol #:
|
| 4
|
|
|
|
|
| EC
61
|
| Ms. Tammy Blake
|
| Vol #:
|
| 4
|
|
|
|
|
| EC
62
|
| Walla Walla Community College
|
| Vol #:
|
| 4
|
|
|
|
|
| EC
63
|
| Mr. Alan Furchtenicht
|
| Vol #:
|
| 4
|
|
|
|
|
| EC
64
|
| Mr. Lee Pulliam
|
| Vol #:
|
| 4
|
|
|
|
|
| EC
65
|
| CA NOW
|
| Vol #:
|
| 4
|
|
|
|
|
| EC
66
|
| Dr. Sholey Argani
|
| Vol #:
|
| 4
|
|
|
|
|
| EC
67
|
| Ms. Merry Loscalzo-Stumpf
|
| Vol #:
|
| 4
|
|
| | | | | | | | |
|
|
|
|
| 2004D-0493
|
| Draft Guidance for Industry on Recommended Approaches to Integration of Genetic Toxicology Study Results
|
|
|
|
|
| NAD
2
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2005D-0195
|
| Guidance for Industry and FDA Staff; The Mammography Quality Standards Act Final Regulations: Modifications and Additions to Policy Guidance Help System #9
|
|
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 1
|
|
| |
|
| 2005D-0330
|
| Guidance for Industry and FDA Review Staff on Collection of Platelets by Automated Methods
|
|
|
|
|
| C
43
|
| Advanced Medical Technology Association (AdvaMed)
|
| Vol #:
|
| 4
|
|
|
|
|
| C 44
|
| Form Letters
|
| Vol #:
|
| 5
|
|
|
|
|
| 2005D-0391
|
| Guidance for Industry and Food and Drug Administration Staff; Functional Indications for Implantable Cardioverter Defibrillators
|
|
|
|
|
| C
3
|
| Cameron Health
|
| Vol #:
|
| 1
|
|
|
|
|
| 2005N-0178
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Regulations Under the Federal Import Milk Act
|
|
|
|
|
| NAL
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2005N-0216
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Medical Devices: Humanitarian Use Devices
|
|
|
|
|
| NAL
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2005N-0217
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Cosmetic Product Voluntary Reporting Program
|
|
|
|
|
| NAL
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2005N-0394
|
| FDAs Communication of Drug Safety Information; Public Hearing
|
|
|
|
|
| C
4
|
| Academy of Medicine of Cleveland/Northern Ohio Medical Association (AMC/NOMA)
|
| Vol #:
|
| 2
|
|
|
|
|
| 2005P-0377
|
| Petition to Rescind the "Generally Recognized as Safe" or GRAS Status for Aluminum Based Food Additives
|
|
|
|
|
| SUP
2
Attachments
|
| Department of the Planet Earth
|
| Vol #:
|
| 3
|
|
|
|
|
| 2005P-0384
|
| Deficient Peripheral Metabolism of Thyroxine to Triiodothyronine
|
|
|
|
|
| SUP 1
|
| E. Pritchard
|
| Vol #:
|
| 1
|
|
|
|
|
| 2005P-0411
|
| Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
|
|
|
|
|
| C 191
|
| D. Branda
|
| Vol #:
|
| 3
|
|
|
|
|
| C 192
|
| B. Moran
|
| Vol #:
|
| 3
|
|
|
|
|
| C 193
|
| A. Jones
|
| Vol #:
|
| 3
|
|
|
|
|
| C 194
|
| J. Hathaway
|
| Vol #:
|
| 3
|
|
|
|
|
| C 195
|
| K. Jones
|
| Vol #:
|
| 3
|
|
|
|
|
| C 196
|
| G. Ross
|
| Vol #:
|
| 3
|
|
|
|
|
| C 197
|
| K. Wightman
|
| Vol #:
|
| 3
|
|
|
|
|
| C 198
|
| A. Epistola
|
| Vol #:
|
| 3
|
|
|
|
|
| C 199
|
| B. Krehbiel
|
| Vol #:
|
| 3
|
|
